======= ADCY1 ======= == Gene Information == * **Official Symbol**: ADCY1 * **Official Name**: adenylate cyclase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=107|107]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q08828|Q08828]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ADCY1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ADCY1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/103072|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of the of adenylate cyclase gene family that is primarily expressed in the brain. This protein is regulated by calcium/calmodulin concentration and may be involved in brain development. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]. * **UniProt Summary**: Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. Mediates responses to increased cellular Ca(2+)/calmodulin levels (By similarity). May be involved in regulatory processes in the central nervous system. May play a role in memory and learning. Plays a role in the regulation of the circadian rhythm of daytime contrast sensitivity probably by modulating the rhythmic synthesis of cyclic AMP in the retina (By similarity). {ECO:0000250|UniProtKB:O88444, ECO:0000250|UniProtKB:P19754}. |Guanylate cyc| |calcium- and calmodulin-responsive adenylate cyclase activity| |adenylate cyclase activity| |cAMP biosynthetic process| |cellular response to forskolin| |response to forskolin| |response to platelet aggregation inhibitor| |activation of protein kinase A activity| |positive regulation of CREB transcription factor activity| |positive regulation of long-term synaptic potentiation| |response to lithium ion| |cAMP metabolic process| |cyclic purine nucleotide metabolic process| |cyclic nucleotide biosynthetic process| |cellular response to glucagon stimulus| |long-term memory| |hippocampal mossy fiber to CA3 synapse| |renal water homeostasis| |response to glucagon| |activation of adenylate cyclase activity| |neuroinflammatory response| |cyclic nucleotide metabolic process| |regulation of long-term synaptic potentiation| |integral component of postsynaptic density membrane| |multicellular organismal water homeostasis| |water homeostasis| |regulation of synaptic vesicle exocytosis| |Schaffer collateral - CA1 synapse| |cellular response to calcium ion| |cellular response to alcohol| |adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway| |cellular response to ketone| |regulation of neurotransmitter secretion| |renal system process| |regulation of synaptic vesicle cycle| |regulation of circadian rhythm| |memory| |cellular response to antibiotic| |adenylate cyclase-activating G protein-coupled receptor signaling pathway| |circadian rhythm| |regulation of neurotransmitter transport| |cAMP-mediated signaling| |purine ribonucleotide biosynthetic process| |positive regulation of synaptic transmission| |response to calcium ion| |purine nucleotide biosynthetic process| |ribonucleotide biosynthetic process| |regulation of regulated secretory pathway| |ribose phosphate biosynthetic process| |purine-containing compound biosynthetic process| |cyclic-nucleotide-mediated signaling| |regulation of synaptic plasticity| |cellular response to metal ion| |response to ketone| |calmodulin binding| |adenylate cyclase-modulating G protein-coupled receptor signaling pathway| |cellular response to inorganic substance| |regulation of exocytosis| |membrane raft| |response to alcohol| |nucleotide biosynthetic process| |G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger| |nucleoside phosphate biosynthetic process| |learning or memory| |positive regulation of DNA-binding transcription factor activity| |cellular response to peptide hormone stimulus| |rhythmic process| |cognition| |response to antibiotic| |purine ribonucleotide metabolic process| |multicellular organismal homeostasis| |ribonucleotide metabolic process| |cellular response to peptide| |activation of protein kinase activity| |purine nucleotide metabolic process| |ribose phosphate metabolic process| |second-messenger-mediated signaling| |glutamatergic synapse| |regulation of neurotransmitter levels| |purine-containing compound metabolic process| |response to metal ion| |axonogenesis| |response to peptide hormone| |cellular response to drug| |axon development| |regulation of DNA-binding transcription factor activity| |cell morphogenesis involved in neuron differentiation| |modulation of chemical synaptic transmission| |regulation of trans-synaptic signaling| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |response to peptide| |neuron projection morphogenesis| |plasma membrane bounded cell projection morphogenesis| |cell projection morphogenesis| |regulation of body fluid levels| |inflammatory response| |cell part morphogenesis| |cellular response to lipid| |response to inorganic substance| |positive regulation of protein kinase activity| |organophosphate biosynthetic process| |nucleobase-containing small molecule metabolic process| |cellular response to organic cyclic compound| |regulation of vesicle-mediated transport| |cell morphogenesis involved in differentiation| |behavior| |positive regulation of kinase activity| |cellular response to organonitrogen compound| |cellular response to hormone stimulus| |carbohydrate derivative biosynthetic process| |positive regulation of transferase activity| |cellular response to nitrogen compound| |neuron projection development| |cell morphogenesis| |brain development| |regulation of secretion by cell| |head development| |regulation of protein kinase activity| |regulation of secretion| |neuron development| |cellular component morphogenesis| |response to lipid| |regulation of kinase activity| |organophosphate metabolic process| |response to hormone| |regulation of cellular localization| |response to organic cyclic compound| |regulation of transferase activity| |central nervous system development| |response to organonitrogen compound| |neuron differentiation| |positive regulation of protein phosphorylation| |response to drug| |carbohydrate derivative metabolic process| |cellular response to oxygen-containing compound| |positive regulation of phosphorylation| |response to nitrogen compound| |nucleobase-containing compound biosynthetic process| |chemical homeostasis| |plasma membrane bounded cell projection organization| |positive regulation of phosphorus metabolic process| |positive regulation of phosphate metabolic process| |cell projection organization| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |cellular response to endogenous stimulus| |positive regulation of protein modification process| |organic cyclic compound biosynthetic process| |G protein-coupled receptor signaling pathway| |defense response| |nervous system process| |integral component of plasma membrane| |organonitrogen compound biosynthetic process| |positive regulation of catalytic activity| |regulation of protein phosphorylation| |response to endogenous stimulus| |ATP binding| |generation of neurons| |response to oxygen-containing compound| |regulation of phosphorylation| |positive regulation of cellular protein metabolic process| |neurogenesis| |cellular nitrogen compound biosynthetic process| |homeostatic process| |cell development| |intracellular signal transduction| |positive regulation of protein metabolic process| |small molecule metabolic process| |positive regulation of molecular function| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |positive regulation of cell communication| |positive regulation of signaling| |regulation of protein modification process| |regulation of transport| |system process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|1.74| |[[:results:exp64|Nocodazole 0.2μM R02 exp64]]|2.17| |[[:results:exp526|Sulforaphane 9μM R08 exp526 no dilution day6]]|2.21| |[[:results:exp33|Rotenone 2μM R00 exp33]]|2.36| |[[:results:exp24|Nocodazole 0.2μM R00 exp24]]|2.54| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.758| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5435 * **Expression level (log2 read counts)**: 4.74 {{:chemogenomics:nalm6 dist.png?nolink |}}